Cargando…
Immune Profiling To Predict Outcome of Clostridioides difficile Infection
There is a pressing need for biomarker-based models to predict mortality from and recurrence of Clostridioides difficile infection (CDI). Risk stratification would enable targeted interventions such as fecal microbiota transplant, antitoxin antibodies, and colectomy for those at highest risk. Becaus...
Autores principales: | Abhyankar, Mayuresh M., Ma, Jennie Z., Scully, Kenneth W., Nafziger, Andrew J., Frisbee, Alyse L., Saleh, Mahmoud M., Madden, Gregory R., Hays, Ann R., Poulter, Mendy, Petri, William A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251209/ https://www.ncbi.nlm.nih.gov/pubmed/32457246 http://dx.doi.org/10.1128/mBio.00905-20 |
Ejemplares similares
-
Novel Biomarkers, Including tcdB PCR Cycle Threshold, for Predicting Recurrent Clostridioides difficile Infection
por: Madden, Gregory R., et al.
Publicado: (2023) -
Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease
por: Young, Mary K, et al.
Publicado: (2022) -
IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
por: Frisbee, Alyse L., et al.
Publicado: (2019) -
Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes
por: Madden, Gregory R., et al.
Publicado: (2022) -
Clostridioides difficile Binary Toxin Is Recognized by the Toll-Like Receptor 2/6 Heterodimer to Induce a Nuclear Factor-κB Response
por: Simpson, Morgan, et al.
Publicado: (2020)